반응식
Cl[CH2:2][C:3]([N:5]1[C:11]2[CH:12]=[CH:13][CH:14]=[CH:15][C:10]=2[C:9](=[O:16])[NH:8][C:7]2[CH:17]=[CH:18][CH:19]=[N:20][C:6]1=2)=[O:4].[CH3:21][O:22][C:23]1[CH:32]=[CH:31][C:26]([CH2:27][CH2:28]CN)=[CH:25][CH:24]=1.C(=O)([O-])O.[Na+].[C:38](#[N:40])C>>[CH3:21][O:22][C:23]1[CH:24]=[CH:25][C:26]([CH2:27][CH2:28][N:40]([CH2:2][C:3]([N:5]2[C:11]3[CH:12]=[CH:13][CH:14]=[CH:15][C:10]=3[C:9](=[O:16])[NH:8][C:7]3[CH:17]=[CH:18][CH:19]=[N:20][C:6]2=3)=[O:4])[CH3:38])=[CH:31][CH:32]=1참가 물질
5
반응물 4
생성물 1
실험 절차
A mixture of 11-chloroacetyl-5,11-dihydro-6H-pyrido- [2,3-b][1,4]benzodiazepine-6-one (288 mg) (German patent 1,936,670), N-(4-methoxyphenethyl)methylamine (182 mg) and sodium hydrogen carbonate (92 mg) in acetonitrile (25 ml) was heated under reflux for 16 hours and evaporated. The residue was partitioned between 2M aqueous sodium hydrogen carbonate solution and dichloromethane and the organic layer washed with brine, dried over MgSO4 and evaporated. The residue was purified by chromatography on silica using dichloromethane plus 0-10% methanol as eluant. Appropriate fractions were combined and evaporated and the residue crystallised from ethyl acetate to give the title compound as a colourless solid, 216 mg (52%).
후처리
- temperaturewas heated
- temperatureunder reflux for 16 hours
- customevaporated
- customThe residue was partitioned between 2M aqueous sodium hydrogen carbonate solution and dichloromethane
- washthe organic layer washed with brine
- dry with materialdried over MgSO4
- customevaporated
- customThe residue was purified by chromatography on silica
- customevaporated
- customthe residue crystallised from ethyl acetate
출처 및 근거
- ORD 기록
- ord-80d480d22c604362833a5a9a03047339
- 출처 데이터셋
- uspto-grants-1995_05
- 특허 번호
- US05418229
연결된 노트
불러오는 중…